During the six months ended June 30, 2021, the Company also issued 300,000 shares of Common Stock in connection with certain vendor contracts. Management valued this issuance of shares at $476,180 and recorded that amount in other general and administrative expense. (See Note 11 Changes in Management.)
Initial Public Offering
On May 3, 2021, the Company’s registration statement on Form S-1 (File No. 333-251959) was declared effective by the SEC and the Company completed its IPO on May 6, 2021. In connection with the IPO, the Company issued and sold 4,291,045 shares of Common Stock and warrants to purchase 4,291,045 shares of Common Stock (including 559,701 shares of Common Stock and warrants to purchase 559,701 shares of Common Stock pursuant to the full exercise of the underwriters' overallotment option), at the combined public offering price of $4.15 for aggregate gross proceeds of approximately $17.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Alfi. Net IPO proceeds of approximately $15.7 million were allocated $11.0 million to Common Stock and $4.7 million to warrants. The warrants were exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and have an exercise price of $4.57 per share.
On May 3, 2021, pursuant to the underwriting agreement for the IPO, the Company issued to the underwriters warrants to purchase up to an aggregate of 186,567 shares of Common Stock (“Underwriter’s Warrants”). The Underwriter’s Warrants may be exercised beginning on May 3, 2022 until May 3, 2026. The initial exercise price of each Underwriter’s Warrant is $5.19 per share.
Warrants Issued and Exercised
Warrants to purchase 4,477,612 shares of Common Stock were issued in connection with the Company’s May 2021 IPO. As of December 31, 2021, warrant holders have exercised warrants to purchase 3,508,227 shares of Common Stock providing Alfi with $16,034,189 in additional funding. As of December 31, 2021, there were warrants to purchase 969,385 shares of Common Stock outstanding.
During the six months ended June 30, 2022, the Company issued a warrant to purchase up to 1,250,000 shares of the Common Stock at a price of $1.51 per share in connection with the Credit Agreement (see Note 6 Debt - Related Parties). No warrants were exercised by warrant holders during the six months ended June 30, 2022. As of June 30, 2022, there were warrants to purchase 2,219,385 shares of Common Stock outstanding.
Share Buy-Back
On June 23, 2021, the Company announced a $2.0 million buy-back of its Common Stock. The buyback was completed on July 9, 2021, with the Company acquiring 137,650 shares of Common Stock, for an aggregate price of $1,999,997, which are recorded as treasury stock. The Company did not purchase any of its shares of Common Stock during the six months ended June 30, 2022.
Employee Equity (Stock) Incentive Plan
The Company has a stock equity incentive plan, the Alfi, Inc. 2018 Stock Incentive Plan (the “2018 Plan”), in which, at its sole discretion, it may award employees Common Stock or Common Stock options, among other awards, as an incentive for performance. Total shares of Common Stock reserved under the 2018 Plan for grants is not to exceed 1,575,029 shares. During the three months ended June 30, 2022 and 2021, respectively, the Company granted -0- and 251,500 Common Stock options under the 2018 Plan. During the six-month periods ended June 30, 2022 and June 30, 2021, respectively, the Company granted -0- and 449,168 Common Stock options under the 2018 Plan.
On June 30, 2022 and 2021, total Common Stock options issued and outstanding under the 2018 Plan were 338,534 and 673,535, respectively, and weighted average strike price per employee stock option was approximately $2.33 and $2.20 per share, respectively. Management recorded credits of $88,861 and $20,823 in stock option expense for the three and six months ended June 30, 2022, respectively, due to the cancellation of 91,405 options due to forfeitures. Management recorded stock-based compensation expense associated with the issuance of employee stock options of $85,256 and $131,942 for the three and six months ended June 30, 2021, respectively.
No employees exercised stock options during the three months ended June 30, 2022. During the six months ended June 30, 2022, two employees exercised stock options and received 25,535 shares of Common Stock.